// App-Quantinova.ai

9005 : Phase III study comparing gefitinib monotherapy (G) to combination therapy with gefitinib, carboplatin, and pemetrexed (GCP) for untreated patients (pts) with advanced non-small cell lung cancer (NSCLC) with EGFR mutations (NEJ009).

Researchers

Presenter

  • Atsushi Nakamura

Principal Investigators

  • Akira Inoue

  • Satoshi Morita

  • Yukio Hosomi

  • Terufumi Kato

  • Tatsuro Fukuhara

  • Akihiko Gemma

  • Kazuhisa Takahashi

  • Yuka Fujita

  • Toshiyuki Harada

  • Koichi Minato

  • Kei Takamura

  • Kunihiko Kobayashi

  • Toshihiro Nukiwa

Medical Centers

  • Sendai Kousei Hospital, Sendai, Japan

  • Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan

  • Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan

  • Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, Japan

  • Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan

  • Department of Respiratory Medicine, Miyagi Cancer Center, Natori, Japan

  • Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan

  • Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan

  • Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan

  • Department of Respiratory Medicine, JCHO Hokkaido Hospital, Sapporo, Japan

  • Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Ota-Shi, Japan

  • First Department of Medicine, Obihiro-Kosei General Hospital, Obihiro, Japan

  • Department of Respiratory Medicine, Saitama Medical University International Medical Center, Saitama, Japan

  • Department of Respiratory medicine, Tohoku University Hospital, Sendai, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Epidermal growth factor receptor

  • Folate Hydrolase 1

Drug/Treatment

  • Carboplatin

  • Pemetrexed

  • gefitinib

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved